Porto, Portugal
+351 960 245 977

Category: cancer immunotherapy

Robotics | IoT

CRISPR Targets Cancer in First Human Trial — What You Need to Know

It’s happening: as early as later this year, the gene-editing power tool CRISPR could be used in its first ever human trial. On Tuesday June 21, an advisory panel from the National Institute of Health (NIH) green lighted a proposal to use the game changing technique to tackle three different kinds of cancer. Scientists at the University of Pennsylvania (UPenn), who are spearheading the small trial, hope to use the technique to edit genes in… read more